Type I Diabetes TCM Therapeutic R&D
Centered on the 'Lower Wasting' theory of Xiao-Ke (Wasting-Thirst) disease, targeting kidney-yin deficiency and essence leakage, using authentic herbs for nourishing yin, supplementing kidney, and astringing essence — AI algorithm-optimized for syndrome differentiation, restoring pancreatic function through the Kidney Meridian of Foot-Shaoyin. Large-scale clinical trial subject recruitment and regulatory submission preparation are underway.
Research Highlights
- •Based on classical TCM formulas, multi-dimensionally optimized by modern AI algorithms
- •Pure herbal formula ingredients, balancing safety and efficacy
- •Ready for scalable production and market deployment
Learn More
Overview
Type I diabetes corresponds to the "Lower Wasting" severe form of Xiao-Ke in TCM. The 'Plain Questions' states: "This person must have frequently consumed sweet and rich foods; richness causes internal heat, sweetness causes middle fullness, thus qi overflows upward, transforming into Xiao-Ke." The root lies in kidney-yin deficiency with essence insecurity, involving the lungs and spleen. ZhengYiKang's Type I Diabetes therapeutic R&D achievement employs "nourishing yin, supplementing kidney; boosting qi, astringing essence; generating fluids, quenching thirst" as the treatment R&D approach, starting from the Kidney meridian while attending to Lung and Spleen.
R&D & Clinical Progress
This is a genuine ZhengYiKang TCM therapeutic R&D program targeting disease mechanisms through formula innovation and pharmacological research. **We are actively preparing large-scale clinical trial subject recruitment and submitting registration/approval materials to the relevant authorities.**
Until national drug or related registration approval is obtained, website content reflects R&D progress and clinical preparation only — not marketing of an approved drug. Patients must strictly follow physician guidance; never stop, reduce, or replace standard medical treatment on your own.
Herb Properties & Meridian Tropism
Mechanism of Action
Type I diabetes is most intimately connected with the Kidney (Foot-Shaoyin) and Spleen (Foot-Taiyin) meridians. "The kidney is the foundation of prenatal constitution" — when the Kidney meridian is deficient, essence is unsecured and leaks downward (glycosuria). "The spleen governs transportation and transformation" — when the Spleen meridian fails, food essence cannot be distributed and instead accumulates as damp-turbidity. The formula primarily uses herbs entering the Kidney and Spleen meridians with guiding herbs to deliver medicinal power directly: nourishing the Kidney meridian's yin to secure essence, strengthening spleen qi to aid transportation, and clearing lung-stomach heat to preserve fluids and quench thirst.
Therapeutic Research Directions
Suitable Scenarios
Usage
Twice daily after meals with warm water. Three 30-day courses recommended with blood glucose monitoring.
Preliminary Research Observations (not formal clinical trial data, for reference only)
Type I users on 3+ courses report smoother glucose curves; some reduced insulin under medical supervision with better energy and sleep.
Health Information Disclaimer
Content on ZhengYiKang (R&D achievements, Health Insights, AI apps) is for non-medical TCM wellness and general health information only. It does not replace in-person care from licensed professionals. Never stop or change medication based on this site alone.
FAQ
- What is ZhengYiKang's Type 1 diabetes therapeutic R&D achievement, and how does it relate to standard care?
- ZhengYiKang's Type 1 diabetes therapeutic R&D achievement is a TCM therapeutic R&D presentation based on the "Lower Wasting" theory — nourish yin, tonify kidney, supplement qi, generate fluids. It is for users interested in daily Type 1 diabetes therapeutic R&D and must be used alongside physician-directed treatment; never adjust insulin on your own.
- What is the TCM "Lower Wasting" theory and its relation to Type 1 therapeutic R&D?
- "Lower Wasting" is a classical TCM pattern within the "Wasting-Thirst" (diabetes) taxonomy, traditionally associated with kidney-yin deficiency and deficient fire. ZhengYiKang's formula offers a therapeutic research reference from nourish-yin and generate-fluids principles — not medical advice.
- How should the Type 1 therapeutic R&D achievement be used?
- Take twice daily, one sachet after meals with warm water, for 2–3 courses (30 days each), combined with blood sugar monitoring and medical guidance. Usage reference only; insulin management must remain under professional supervision.
- Can the Type 1 therapeutic R&D achievement replace insulin therapy?
- No. Type 1 diabetes requires exogenous insulin. ZhengYiKang's therapeutic R&D achievement cannot replace any insulin regimen. Always follow your physician's plan; never stop or adjust insulin on your own.
- How does ZhengYiKang's Type 1 formula relate to classical prescriptions and AI optimization?
- The formula inherits classical TCM prescription principles and uses ZhengYiKang's proprietary AI algorithms to optimize authentic herb compatibility — an R&D achievement presentation. AI is a research tool; the product is non-medical therapeutic R&D information, not a drug advertisement.
Comments
1 viewsAll Comments (0)
Loading comments…
Collaboration Models
We invite pharmaceutical companies, research institutions, and investors worldwide to join us in advancing TCM modernization and globalization
Technology Licensing
Joint R&D
Investment Partnership
Market Distribution
Why Partner With Us
Scientific Excellence
Ancient TCM formulas optimized by modern AI algorithms, with proprietary intellectual property
Market Potential
Trillion-dollar TCM health market with sustained demand growth
World-Class Team
Cross-disciplinary team of TCM experts and AI scientists
Full-Chain Support
End-to-end partnership support from R&D to commercialization
